Apply for the African Research Initiative for Scientific Excellence (ARISE) programme, funded by the EU through the Pan-African Programme to empower early-career African researchers to deliver cutting-edge research across Africa. For more details visit 👉 https://t.co/upyCxZ96iB
Excited to share latest work in @CellCellPress from our Prometheus consortium (pic). Our charge is to discover and develop human antibody-based therapeutics against emerging viral threats. See thread below.
Author version of paper: https://t.co/yq9q9Uv0ie
Individuals with pre-existing immunity to SARS-CoV-2 respond strongly to the first dose of mRNA vaccine, equal or better than naive individuals to the second dose. Nice teamwork with the great @VivianaSimonLab. This is now out in NEJM. https://t.co/d9nBrOd1DD
Great keynote lecture by @KizzyPhD for Frontiers in Vaccinology 2020 @UMCVD. Thanks for the message of hope, not only for a COVID-19 vaccine, but also for the future of Science.
New mSphere of Influence commentary, by Esther Ndungo: @theRealGechi learns from nature-antibody profiles important for protection of young infants. https://t.co/wVfUsffamW @ASMicrobiology#mSphere
First lab preprint! Great work by Jose Lemme characterizing the immune response of neutrophils to bacteria in a human intestinal enteroid model.
https://t.co/sOamyWRMVW
How does the immune system work? Will there be #COVID19 vaccines? @BioRender & I put together ‘immunology 101 tweetorial for non-immunologists’. @jerryguartist, @shizaoki, @JungHeeSciViz also made this accompanying video. Please share widely! (1/n)
https://t.co/eoNOqz2CXr
1) There is a lot of talk about decaying antibodies. I would like to walk you through a few findings about antibodies to SARS-CoV-2 that we put on medRxiv on Friday. Ill do this slowly over the day (while being in nonstop conference calls). But I feel this needs to get out there.
Replication-competent VSV for studying SARS-CoV-2 spike-mediated cell entry & its inhibition: @ChandranLab @Jangra_RohitK @EugeDieterle @HaslwanterD & Herbert generate infectious rVSV encoding #SARSCoV2 Spike suitable for screening & mechanistic studies https://t.co/FbNVRmkWkr
Thanks to Dr Galit Alter and Dr Bali Pulendran for a great session on systems serology, highlighting its potential to generate A LOT of data with the exciting challenge of teasing out what it all means #VKSvaxcovid19